Nifty
Sensex
:
:
12086.70
41009.71
114.90 (0.96%)
428.00 (1.05%)

Pharmaceuticals & Drugs

Rating :
71/99  (View)

BSE: 524742 | NSE: CAPLIPOINT

306.55
9.65 (3.25%)
13-Dec-2019 | 3:49PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  300.00
  •  308.90
  •  300.00
  •  296.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  91329
  •  279.97
  •  466.90
  •  280.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,320.72
  • 11.05
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,168.27
  • 0.72%
  • 2.89

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 69.03%
  • 1.65%
  • 17.05%
  • FII
  • DII
  • Others
  • 0.04%
  • 0.00%
  • 12.23%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 17.33

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 13.19

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 22.69

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 20.64
  • 32.15
  • 24.85

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.62
  • 13.35
  • 11.65

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.35
  • 21.51
  • 19.72

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 19
Sep 18
Var%
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Net Sales
227.20
155.86
45.77%
192.55
146.46
31.47%
187.34
143.41
30.63%
159.03
141.61
12.30%
Expenses
156.09
100.08
55.97%
125.17
93.43
33.97%
122.58
94.69
29.45%
101.27
90.82
11.51%
EBITDA
71.12
55.78
27.50%
67.38
53.03
27.06%
64.76
48.72
32.92%
57.76
50.79
13.72%
EBIDTM
31.30%
35.79%
34.99%
36.21%
34.57%
33.97%
36.32%
35.87%
Other Income
6.89
7.01
-1.71%
4.47
1.61
177.64%
2.67
2.90
-7.93%
7.74
2.33
232.19%
Interest
0.08
0.02
300.00%
0.01
0.01
0.00%
0.01
0.01
0.00%
0.02
0.02
0.00%
Depreciation
7.40
5.58
32.62%
7.39
5.45
35.60%
6.72
6.18
8.74%
5.67
4.53
25.17%
PBT
70.53
57.20
23.30%
64.45
49.17
31.08%
60.69
45.43
33.59%
59.81
48.58
23.12%
Tax
13.25
13.70
-3.28%
14.38
11.78
22.07%
10.84
10.13
7.01%
14.00
11.10
26.13%
PAT
57.27
43.50
31.66%
50.07
37.39
33.91%
49.86
35.29
41.29%
45.81
37.48
22.23%
PATM
25.21%
27.91%
26.00%
25.53%
26.61%
24.61%
28.80%
26.47%
EPS
7.58
5.75
31.83%
6.64
4.95
34.14%
6.59
4.68
40.81%
6.06
4.97
21.93%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Jun 12
Jun 11
Net Sales
766.12
648.69
539.84
401.65
238.72
251.77
173.09
127.03
107.22
80.78
Net Sales Growth
30.44%
20.16%
34.41%
68.25%
-5.18%
45.46%
36.26%
18.48%
32.73%
 
Cost Of Goods Sold
349.02
288.78
238.18
184.93
121.16
135.62
102.58
84.45
77.36
60.88
Gross Profit
417.10
359.91
301.66
216.72
117.56
116.15
70.50
42.58
29.85
19.89
GP Margin
54.44%
55.48%
55.88%
53.96%
49.25%
46.13%
40.73%
33.52%
27.84%
24.62%
Total Expenditure
505.11
416.84
344.52
276.84
174.51
192.06
136.90
104.68
96.06
71.58
Power & Fuel Cost
-
13.76
10.98
9.91
7.56
8.61
3.07
1.12
0.84
0.68
% Of Sales
-
2.12%
2.03%
2.47%
3.17%
3.42%
1.77%
0.88%
0.78%
0.84%
Employee Cost
-
45.58
37.61
29.71
17.92
18.24
12.63
7.69
6.28
4.14
% Of Sales
-
7.03%
6.97%
7.40%
7.51%
7.24%
7.30%
6.05%
5.86%
5.13%
Manufacturing Exp.
-
43.49
37.11
28.56
14.33
16.04
7.42
3.07
1.63
1.54
% Of Sales
-
6.70%
6.87%
7.11%
6.00%
6.37%
4.29%
2.42%
1.52%
1.91%
General & Admin Exp.
-
20.82
12.27
13.78
8.15
7.97
6.54
4.67
3.58
3.00
% Of Sales
-
3.21%
2.27%
3.43%
3.41%
3.17%
3.78%
3.68%
3.34%
3.71%
Selling & Distn. Exp.
-
2.08
5.92
9.41
2.29
2.85
1.46
1.02
0.91
0.67
% Of Sales
-
0.32%
1.10%
2.34%
0.96%
1.13%
0.84%
0.80%
0.85%
0.83%
Miscellaneous Exp.
-
2.33
2.45
0.55
3.10
2.72
3.19
2.66
5.44
0.66
% Of Sales
-
0.36%
0.45%
0.14%
1.30%
1.08%
1.84%
2.09%
5.07%
0.82%
EBITDA
261.02
231.85
195.32
124.81
64.21
59.71
36.19
22.35
11.16
9.20
EBITDA Margin
34.07%
35.74%
36.18%
31.07%
26.90%
23.72%
20.91%
17.59%
10.41%
11.39%
Other Income
21.77
19.03
12.67
9.96
3.66
3.03
3.72
2.10
2.51
2.55
Interest
0.12
0.58
0.61
0.52
0.34
0.97
0.68
0.77
1.26
1.20
Depreciation
27.18
23.43
19.00
13.30
7.48
8.38
3.54
1.54
1.24
2.32
PBT
255.48
226.88
188.38
120.95
60.05
53.39
35.69
22.14
11.17
8.22
Tax
52.47
50.32
43.74
25.44
14.28
12.26
9.76
8.12
3.14
1.91
Tax Rate
20.54%
22.18%
23.22%
21.03%
23.78%
22.96%
27.35%
36.68%
28.11%
23.24%
PAT
203.01
176.56
144.78
95.61
45.77
41.04
25.85
13.98
8.01
6.28
PAT before Minority Interest
203.19
176.56
144.63
95.50
45.77
41.13
25.93
14.02
8.03
6.31
Minority Interest
0.18
0.00
0.15
0.11
0.00
-0.09
-0.08
-0.04
-0.02
-0.03
PAT Margin
26.50%
27.22%
26.82%
23.80%
19.17%
16.30%
14.93%
11.01%
7.47%
7.77%
PAT Growth
32.12%
21.95%
51.43%
108.89%
11.53%
58.76%
84.91%
74.53%
27.55%
 
Unadjusted EPS
26.87
23.35
19.26
12.65
30.28
27.16
17.11
9.25
5.30
4.16

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Jun 12
Jun 11
Shareholder's Funds
632.91
363.83
224.76
128.14
93.19
61.74
43.14
33.58
29.08
Share Capital
15.13
15.12
15.12
15.11
15.11
15.11
15.11
15.11
15.11
Total Reserves
610.93
345.42
209.56
111.40
78.08
46.63
28.03
18.47
13.97
Non-Current Liabilities
23.42
27.86
19.90
13.69
10.39
10.42
8.66
4.29
1.82
Secured Loans
0.29
0.32
0.48
0.73
0.88
2.07
3.48
1.55
0.08
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.40
1.63
0.82
0.81
0.38
0.27
0.20
Current Liabilities
86.11
108.67
113.36
125.04
124.97
107.58
83.01
69.20
40.44
Trade Payables
60.47
94.23
78.60
55.71
41.56
31.50
25.64
21.26
17.06
Other Current Liabilities
24.20
13.86
33.09
60.39
72.11
66.42
50.85
38.33
10.71
Short Term Borrowings
0.00
0.00
0.00
0.00
0.05
0.05
0.05
5.20
9.46
Short Term Provisions
1.44
0.58
1.67
8.94
11.25
9.60
6.47
4.41
3.22
Total Liabilities
742.52
500.45
358.38
267.14
228.82
179.92
134.90
107.12
71.37
Net Block
226.84
169.48
151.83
144.23
113.13
102.24
32.71
27.54
24.95
Gross Block
271.51
231.79
195.15
180.76
142.71
123.06
50.06
43.36
39.53
Accumulated Depreciation
44.67
62.31
43.31
36.53
29.58
20.82
17.36
15.82
14.58
Non Current Assets
248.83
196.34
179.16
148.61
146.95
131.30
96.21
53.41
30.12
Capital Work in Progress
9.70
15.29
3.42
0.23
30.63
24.54
48.98
12.79
0.17
Non Current Investment
0.33
0.33
13.24
0.44
0.45
0.44
1.19
1.14
1.15
Long Term Loans & Adv.
11.95
11.23
10.67
3.71
2.75
3.67
10.83
11.94
3.85
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
493.69
304.11
179.22
118.53
81.87
48.61
38.70
53.71
41.25
Current Investments
69.62
46.34
4.20
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
37.45
28.46
22.29
18.81
13.66
9.79
10.42
6.38
5.50
Sundry Debtors
159.81
125.88
33.02
7.95
5.66
0.09
0.86
7.28
8.33
Cash & Bank
152.99
79.28
93.07
68.10
45.37
26.82
16.84
31.80
21.62
Other Current Assets
73.83
6.88
7.32
11.09
17.18
11.90
10.57
8.25
5.80
Short Term Loans & Adv.
64.61
17.28
19.31
12.58
11.08
8.16
5.61
4.50
3.44
Net Current Assets
407.58
195.44
65.86
-6.51
-43.10
-58.97
-44.31
-15.49
0.81
Total Assets
742.52
500.45
358.38
267.14
228.82
179.91
134.91
107.12
71.37

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Jun 12
Jun 11
Cash From Operating Activity
83.42
66.49
67.61
42.40
49.88
59.83
31.95
27.92
14.25
PBT
226.88
188.38
120.95
60.05
53.39
35.69
22.14
11.17
8.22
Adjustment
19.12
14.84
8.61
3.87
6.21
2.14
-0.21
-0.25
2.06
Changes in Working Capital
-120.06
-100.38
-38.39
-5.13
1.96
29.32
15.81
18.89
4.49
Cash after chg. in Working capital
125.94
102.84
91.16
58.78
61.56
67.15
37.75
29.81
14.77
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-42.51
-36.35
-23.55
-16.38
-11.67
-7.32
-5.80
-1.89
-0.52
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-100.46
-69.02
-36.11
-5.72
-22.66
-43.89
-45.44
-16.44
-6.90
Net Fixed Assets
58.45
-48.43
-19.56
-7.66
-25.72
-48.50
-43.00
-16.08
Net Investments
-120.03
-29.43
-17.35
0.01
-0.90
0.75
-0.05
-0.04
Others
-38.88
8.84
0.80
1.93
3.96
3.86
-2.39
-0.32
Cash from Financing Activity
89.79
-11.60
-6.74
-13.95
-8.67
-5.96
-1.48
-1.30
-0.37
Net Cash Inflow / Outflow
72.76
-14.13
24.76
22.73
18.55
9.99
-14.97
10.18
6.98
Opening Cash & Equivalents
77.17
91.31
66.55
45.37
26.82
16.84
31.80
21.62
14.64
Closing Cash & Equivalent
150.65
77.17
91.31
68.10
45.37
26.82
16.84
31.80
21.62

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Jun 14
Jun 13
Jun 12
Jun 11
Book Value (Rs.)
82.78
47.69
29.73
16.25
11.84
7.68
5.22
3.95
3.36
ROA
28.41%
33.68%
30.54%
18.46%
20.12%
16.48%
11.59%
9.00%
8.84%
ROE
35.79%
49.43%
54.97%
43.13%
55.78%
53.24%
40.49%
29.10%
24.90%
ROCE
45.59%
64.08%
69.03%
55.41%
71.11%
68.99%
56.69%
34.62%
26.87%
Fixed Asset Turnover
2.58
2.53
2.14
1.48
1.89
2.00
2.73
2.61
2.04
Receivable days
80.37
53.72
18.62
10.40
4.17
1.00
11.66
26.30
37.63
Inventory Days
18.54
17.16
18.68
24.83
17.00
21.31
24.06
20.01
24.84
Payable days
65.76
89.68
88.17
103.48
69.75
79.69
85.60
79.07
88.42
Cash Conversion Cycle
33.15
-18.80
-50.88
-68.24
-48.58
-57.39
-49.89
-32.75
-25.95
Total Debt/Equity
0.00
0.00
0.00
0.02
0.02
0.06
0.12
0.23
0.38
Interest Cover
391.22
309.72
235.08
179.35
56.11
53.29
29.73
9.88
7.84

News Update


  • Caplin Point Laboratories’ arm gets USFDA’s nod for Sodium Nitroprusside injection
    3rd Dec 2019, 12:44 PM

    Sodium Nitroprusside had US sales data of approximately $8 million for the 12-months period ending March 2019

    Read More
  • Caplin Point Lab - Quarterly Results
    30th Oct 2019, 12:51 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.